Bode
August 30, 2022
A recent study has found that China’s first self-developed HPV vaccine, Cecolin, can offer female adults full immunity against two human papillomavirus (HPV). A group of Chinese researchers analysed data from 66-month follow-up visits as part of the bivalent vaccine’s Phase 3 clinical trial. They found that its efficacy...

